Immune Checkpoint Therapy and the Search for Predictive Biomarkers

Cancer Journal - United States
doi 10.1097/ppo.0000000000000185
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Identification of Responders to Immune Checkpoint Therapy: Which Biomarkers Have the Highest Value?

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2019English

Predictive Biomarkers for Checkpoint Immunotherapy: Current Status and Challenges for Clinical Application

Cancer immunology research
Cancer ResearchImmunology
2018English

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors

Advances in Therapy
MedicinePharmacology
2019English

P1.01-49 irAE, Possible Predictive Markers for Immune Checkpoint Inhibitors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy

Clinical Cancer Research
Cancer ResearchOncology
2019English

Biomarkers for Immune Checkpoint Inhibitors: The Importance of Tumor Topography and the Challenges to Cytopathology

Cancer cytopathology
Cancer ResearchOncology
2017English

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy

Frontiers in Immunology
AllergyImmunology
2020English

Neutrophil Lymphocyte Ratio and Duration of Prior Anti-Angiogenic Therapy as Biomarkers in Metastatic RCC Receiving Immune Checkpoint Inhibitor Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2017English

On the Mechanism of Anti-Cd39 Immune Checkpoint Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy